Power Sean A's Form 4 filing
TG Therapeutics, Inc. (TGTX) · filed Jan 5, 2024
- Accession no.
- 0001437749-24-000756
- Filed
- Jan 5, 2024
- Trade date
- Jan 3-5, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $809.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Power Sean ACIK 0001538845 | Officer (CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2024 | Common Stock | SSaleDisposed | −47,867 | $16.91 | −$809,430.97 | 606,969 | Direct | |
| Jan 5, 2024 | Common Stock | AGrant or awardAcquired | +75,000 | $0.00 | $0 | 681,969 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.